An Open Study to Assess the Robustness of the CRC749 Inhaler

NCT02474017 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
COPD

Interventions

DRUG: MGR001
DEVICE: CRC749 inhaler

Sponsor

Mylan Pharma UK Ltd.